{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "priceEpsCurrentYear": 0.20923781, "sharesOutstanding": 1504560, "bookValue": 9.515, "fiftyDayAverage": 4.92254, "fiftyDayAverageChange": -0.80473995, "fiftyDayAverageChangePercent": -0.16348062, "twoHundredDayAverage": 6.15152, "twoHundredDayAverageChange": -2.0337195, "twoHundredDayAverageChangePercent": -0.3306044, "marketCap": 6195477, "forwardPE": 0.20923781, "priceToBook": 0.43276933, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "exchange": "NCM", "shortName": "Phio Pharmaceuticals Corp.", "longName": "Phio Pharmaceuticals Corp.", "messageBoardId": "finmb_140969529", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "REGULAR", "regularMarketChangePercent": 22.553583, "regularMarketPrice": 4.1178, "firstTradeDateMilliseconds": 1336656600000, "priceHint": 4, "regularMarketChange": 0.75780034, "regularMarketTime": 1684255955, "regularMarketDayHigh": 4.92, "regularMarketDayRange": "3.8 - 4.92", "regularMarketDayLow": 3.8, "regularMarketVolume": 7928430, "regularMarketPreviousClose": 3.36, "bid": 4.2, "ask": 4.28, "bidSize": 14, "askSize": 9, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 4.24, "averageDailyVolume3Month": 121925, "averageDailyVolume10Day": 23510, "fiftyTwoWeekLowChange": 1.0078003, "fiftyTwoWeekLowChangePercent": 0.32405156, "fiftyTwoWeekRange": "3.11 - 12.27", "fiftyTwoWeekHighChange": -8.152201, "fiftyTwoWeekHighChangePercent": -0.664401, "fiftyTwoWeekLow": 3.11, "fiftyTwoWeekHigh": 12.27, "dividendDate": 1579046400, "earningsTimestamp": 1683838802, "earningsTimestampStart": 1691578740, "earningsTimestampEnd": 1692014400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -9.72, "epsForward": 19.68, "epsCurrentYear": 19.68, "displayName": "Phio Pharmaceuticals", "symbol": "PHIO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "257 Simarano Drive", "address2": "Suite 101", "city": "Marlborough", "state": "MA", "zip": "01752", "country": "United States", "phone": "508 767 3861", "website": "https://www.phiopharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint protein PD-1 for immunotherapy; PH-894 that silences the epigenetic protein BRD4, which is an intracellular regulator of gene expression for use in T and tumor cells; and PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert J. Bitterman", "age": 71, "title": "Pres, CEO & Chairman", "yearBorn": 1951, "fiscalYear": 2022, "totalPay": {"raw": 141462, "fmt": "141.46k", "longFmt": "141,462"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Caitlin  Kontulis", "age": 36, "title": "VP of Fin. & Admin. and Sec.", "yearBorn": 1986, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}